532.00
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché IDXX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$520.87
Aprire:
$523.05
Volume 24 ore:
569.89K
Relative Volume:
0.93
Capitalizzazione di mercato:
$42.78B
Reddito:
$3.93B
Utile/perdita netta:
$894.97M
Rapporto P/E:
49.17
EPS:
10.82
Flusso di cassa netto:
$837.70M
1 W Prestazione:
+1.01%
1M Prestazione:
+1.54%
6M Prestazione:
+23.55%
1 anno Prestazione:
+11.93%
Idexx Laboratories Inc Stock (IDXX) Company Profile
Nome
Idexx Laboratories Inc
Settore
Industria
Telefono
(207) 556-0300
Indirizzo
ONE IDEXX DRIVE, WESTBROOK, ME
Confronta IDXX con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
IDXX
Idexx Laboratories Inc
|
532.00 | 42.36B | 3.93B | 894.97M | 837.70M | 10.82 |
![]()
TMO
Thermo Fisher Scientific Inc
|
427.62 | 157.79B | 42.90B | 6.52B | 6.72B | 17.05 |
![]()
DHR
Danaher Corp
|
189.91 | 138.02B | 23.82B | 3.77B | 4.90B | 5.15 |
![]()
A
Agilent Technologies Inc
|
116.19 | 32.08B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
187.38 | 27.28B | 15.50B | 1.33B | 2.16B | 7.34 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-07-01 | Iniziato | Jefferies | Buy |
2024-12-02 | Iniziato | Leerink Partners | Outperform |
2024-07-25 | Iniziato | BTIG Research | Buy |
2024-01-30 | Downgrade | Piper Sandler | Overweight → Neutral |
2023-12-07 | Iniziato | Exane BNP Paribas | Outperform |
2023-12-04 | Aggiornamento | Cleveland Research | Neutral → Buy |
2023-08-02 | Downgrade | Atlantic Equities | Overweight → Neutral |
2022-07-25 | Downgrade | Stifel | Buy → Hold |
2022-07-21 | Aggiornamento | Goldman | Neutral → Buy |
2022-07-12 | Iniziato | Piper Sandler | Overweight |
2022-05-05 | Downgrade | BofA Securities | Buy → Neutral |
2022-02-08 | Iniziato | Atlantic Equities | Overweight |
2021-11-18 | Iniziato | Morgan Stanley | Overweight |
2021-08-05 | Ripresa | Credit Suisse | Outperform |
2021-07-12 | Downgrade | Guggenheim | Buy → Neutral |
2021-02-17 | Iniziato | Barclays | Overweight |
2019-09-09 | Iniziato | Goldman | Neutral |
2019-05-23 | Iniziato | Guggenheim | Buy |
2018-11-02 | Reiterato | BofA/Merrill | Buy |
2018-05-07 | Reiterato | Stifel | Buy |
2018-01-16 | Iniziato | Piper Jaffray | Overweight |
2017-08-23 | Aggiornamento | BofA/Merrill | Neutral → Buy |
2017-07-28 | Aggiornamento | CL King | Neutral → Buy |
2017-02-03 | Downgrade | Feltl & Co. | Hold → Sell |
2016-09-29 | Ripresa | BofA/Merrill | Neutral |
2016-08-16 | Reiterato | Stifel | Buy |
2016-08-03 | Aggiornamento | Northcoast | Sell → Neutral |
2016-07-20 | Reiterato | Canaccord Genuity | Buy |
2016-04-19 | Reiterato | Canaccord Genuity | Buy |
2016-04-01 | Iniziato | CL King | Neutral |
2016-03-21 | Reiterato | Stifel | Buy |
2016-02-04 | Iniziato | Credit Suisse | Outperform |
2015-10-29 | Reiterato | Stifel | Buy |
2015-08-28 | Downgrade | Raymond James | Outperform → Mkt Perform |
2015-08-13 | Reiterato | Stifel | Buy |
2015-07-23 | Reiterato | Canaccord Genuity | Buy |
Mostra tutto
Idexx Laboratories Inc Borsa (IDXX) Ultime notizie
What drives IDEXX Laboratories Inc. stock priceRapid growth trajectories - jammulinksnews.com
What analysts say about IDEXX Laboratories Inc. stockUnmatched profit growth - jammulinksnews.com
Should You Consider Adding IDEXX Laboratories (IDXX) to Your Portfolio? - Yahoo Finance
Is IDEXX Laboratories Inc. a good long term investmentUnprecedented growth rates - jammulinksnews.com
IDEXX Laboratories Inc. Surges to 413th in Trading Volume with $253 Million in Shares Traded - AInvest
Here's What to Expect From IDEXX Laboratories' Next Earnings Report - MSN
Agree To Buy Idexx Laboratories At $490, Earn 9.8% Annualized Using Options - Nasdaq
IDEXX Laboratories Inc. Stock Analysis and ForecastFree Stock Selection - Autocar Professional
Leerink Partners Forecasts Strong Price Appreciation for IDEXX Laboratories (NASDAQ:IDXX) Stock - MarketBeat
How high can IDEXX Laboratories Inc. stock price go in 20253x Return Stock Radar - beatles.ru
Leerink Partners Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Raises Target Price to $600 - 富途牛牛
Expert Outlook: IDEXX Laboratories Through The Eyes Of 6 Analysts - 富途牛牛
**IDEXX Laboratories: A High-Quality Business with Strong Fundamentals and Attractive Long-Term Growth Prospects** - AInvest
IDEXX Laboratories, Inc.: A Business With Very Strong Fundamentals (NASDAQ:IDXX) - Seeking Alpha
Idexx Laboratories (IDXX) Sees Raised Price Target from Leerink Analyst | IDXX Stock News - GuruFocus
Are Robust Financials Driving The Recent Rally In IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Stock? - 富途牛牛
Here's What To Expect From IDEXX Laboratories' Next Earnings Report - Barchart.com
IDEXX Laboratories Expands Board with New Director - The Globe and Mail
IDEXX Laboratories (IDXX) Announces Election of New Independent Director - GuruFocus
IDEXX Laboratories Appoints Joseph L. (Jay) Hooley To Board - citybiz
IDEXX Laboratories Elects Joseph L. (Jay) Hooley to Board of Directors - AInvest
STOK files 8-K; releases data guiding Phase 3 EMPEROR dosing | IDXX SEC FilingForm 8-K - Stock Titan
What Does IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Share Price Indicate? - Yahoo Finance
Here's How Much You'd Have If You Invested $1000 in Idexx Laboratories a Decade Ago - Yahoo Finance
IDEXX Laboratories Insiders Sell US$2.4m Of Stock, Possibly Signalling Caution - simplywall.st
Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 20 Years - Benzinga
Stifel Nicolaus Issues Positive Forecast for IDEXX Laboratories (NASDAQ:IDXX) Stock Price - MarketBeat
IDEXX Laboratories (NASDAQ:IDXX) Coverage Initiated by Analysts at Jefferies Financial Group - MarketBeat
Idexx Laboratories stock hits 52-week high at $546.61 By Investing.com - Investing.com South Africa
Idexx Laboratories stock hits 52-week high at $546.61 - Investing.com
IDEXX Laboratories (IDXX) Price Target Raised by Stifel | IDXX Stock News - GuruFocus
(PDF) Performance comparison of SNAP® 4Dx® plus and AccuPlex®4 for the detection of antibodies to Borrelia burgdorferi and Anaplasma phagocytophilum - researchgate.net
Stifel Adjusts Price Target on IDEXX Laboratories to $540 From $510, Maintains Hold Rating - MarketScreener
Investing in IDEXX Laboratories (NASDAQ:IDXX) Five Years Ago Would Have Delivered You a 58% Gain - 富途牛牛
IDEXX Laboratories, Inc.(NasdaqGS: IDXX) dropped from Russell 1000 Dynamic Index - MarketScreener
(PDF) Validation of immune complex dissociation methods for use with heartworm antigen tests - researchgate.net
What Makes IDEXX Laboratories (IDXX) a Good Investment? - Insider Monkey
IDEXX Laboratories to Release 2025 Second Quarter Financial Results | IDXX Stock News - GuruFocus
Idexx Laboratories stock hits 52-week high at $530.74 - Investing.com
IDEXX Laboratories (IDXX) Price Target Hiked to $580 at Leerink Partners - Insider Monkey
12 Best Healthcare Stocks to Buy Now - Insider Monkey
IDEXX Laboratories Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga
IDEXX Laboratories (IDXX) Sees Price Target Raised by Leerink Pa - GuruFocus
Three Lawmakers Bought This Biotech Stock Before Supporting A Bill That Could Boost Its Value: It's Now Up 44% - Benzinga
Idexx Laboratories Inc Azioni (IDXX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):